CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the safety and ...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 1 other location
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Ogden, Utah, United States of America and 226 other locations
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...
Phase 1
Salt Lake City, Utah, United States and 16 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Salt Lake City, Utah, United States and 117 other locations
to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...
Phase 1, Phase 2
West Valley City, Utah, United States of America and 10 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Ogden, Utah, United States and 147 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Salt Lake City, Utah, United States and 50 other locations
to test the safety of an investigational drug called CFI-402257 alone in advanced solid tumors and in combination with Fulvestrant in advanced breast...
Phase 1, Phase 2
West Valley City, Utah, United States and 3 other locations
be open to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer. Dose expansion will ...
Phase 1
Salt Lake City, Utah, United States and 1 other location
how treatment with Fulvestrant (FASLODEX) or Anastrozole (ARIMIDEX) effects disease progression for women with locally advanced or metastatic breast...
Phase 3
Salt Lake City, Utah, United States and 118 other locations
Clinical trials
Research sites
Resources
Legal